脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
这是否反映了非酒精性脂肪性肝病或肝脏的直接血糖损伤，尚无法判断。
Whether this reflects nonalcoholic fatty liver disease or direct glycemic injury of the liver remains to be determined.
事实上，白细胞介素- 1在这种情况下可以诱导肝细胞脂肪沉积，这是非酒精性脂肪性肝病的一个特征。
In fact, interleukin-1 in this scenario can induce fat deposition in the hepatocytes which is one of the characteristics on non-alcoholic fatty liver disease.
他吃了大量的脂肪性或油腻的食物后感到饱胀吗？
目的评价肝安汤对高脂血症性脂肪性肝炎的疗效。
Objective To evaluate the therapeutic effect of Ganan decoction in hyperlipidemic fatty hepatitis.
但是，如今人们正在吃更多的烧烤和脂肪性食物，这些食物对人类的身体都是酸性的和不好的。
But nowadays, people are eating more deep-fried and greasy foods that are acidic and bad for the body.
此外，肝脏基金会估计有5%的美国人患非酒精性脂肪性肝炎。
Additionally, the liver foundation estimates that about 5 percent of Americans have NASH.
我们展示了人类免疫细胞在体外非酒精性脂肪性肝病，说明酒的确影响天然免疫炎症相关的细菌和病毒的感染。
What we showed in human immune cells in vitro petri dish-type alcohol administration is that alcohol indeed affects inflammation and in turn innate immunity related to bacterial and viral infections.
新的研究包括55个患非酒精性脂肪性肝炎且有胰岛素抵抗或2型糖尿病的患者。
The new study included 55 people with nonalcoholic steatohepatitis and either insulin resistance or type 2 diabetes.
不同种类磷脂酰胆碱的结构是不同种类的脂肪性分子结合到一个常规核上。
Various types of phosphatidylcholines house different kinds of fatty molecules linked to a common core.
此文就脂肪性肝病向原发性肝癌进展的可能机制作一综述。
This article is mainly about the possible pathogenesis how fatty liver disease progress to liver cancer.
在发达国家，非酒精性脂肪性肝病(NAFLD)是一种很常见的慢性肝脏疾病。
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
脂肪性肝病是多种原因引起的病变主体在肝小叶、以肝细胞脂肪变性和脂肪蓄积过多为主的临床病理综合征。
Fatty liver disease (FLD) is a clinicopathological syndrome caused by a variety of reasons. The main lesions are in hepatic lobule with steatohepatitis and accumulation of triglycerides in the liver.
现代医学已经对它进行了比较深入的研究，但至今仍未找到脂肪性肝病的特效治疗药物。
Western Medicine has already carried on an in-depth study on it, but has not find out the miracle drug as yet.
结果，长期饮用高度白酒后形成慢性酒精中毒的患者，肝脏增大者占54%，而且其肝实质有不同程度的脂肪性变声象图。
Results: in the patients with chronic alcoholism caused by lastingly drinking high degree wine, 54% had hepatomegaly and liver parenchyma showed lipoidal-change acoustic image at varied degree.
目的探讨非肥胖的糖耐量受损(igt)者的非酒精性脂肪性肝病(NAFLD)与代谢综合征(MS)的关系。
Objective to investigate the relationship between metabolic syndrome (MS) and nonalcoholic fatty liver disease (NAFLD) in non-obese impaired glucose tolerant (IGT) subjects.
结论：中药可抑制肝脏脂质过氧化，拮抗其膜流动性降低，具有良好的防治脂肪性肝炎作用。
Conclusion: TCM may inhibit hepatic lipid peroxidation, antagonize reduction of membrane fluidity, and have better effect on preventing and treating fatty hepatitis.
目的评价胆宁片治疗非酒精性脂肪性肝病（湿热型）的临床疗效。
ObjectiveTo evaluate the therapeutic effect of Danning Tablet (DNT) on patients with non-alcoholic fatty liver (NAFL) of damp-heat Syndrome type.
目的：观察疏肝降浊汤治疗非酒精性脂肪性肝病的临床疗效及安全性。
Objective: To observe the clinical effect and safety of Shugan Jiangzhuo Decoction in treating nonalcoholic fatty liver disease (NAFLD).
联合治疗应是未来非酒精性脂肪性肝炎临床试验的范例吗？
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
非乙醇性脂肪性肝病（NAFLD）是一种常见的慢性肝病，其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎（NASH）、肝纤维化及肝硬化。
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.
目的：研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
Objetive: To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases (NAFLD).
本文就双环醇在脂肪性肝病的基础研究与临床应用的进展加以综述。
This article is a review about the advance in basic and clinical research.
我们必须认识到所有非酒精性脂肪性肝炎患者发病机制并不是单一的信号途径。
I think that it probably has to do with the fact that the pathogenesis of all patients with non-alcoholic steatohepatitis, is probably not a single way or a single pathway.
目的：观察降脂平肝汤对非酒精性脂肪性肝病大鼠胰岛素抵抗的影响，探讨其作用机制。
Objective: to observe the effect of decoction of lowering lipin to calm the liver on insulin resistance of non-alcohol adiposis hepatica rats, and to approach the mechanism of action as well.
目的研究罗格列酮联合还原型谷胱甘肽对非酒精性脂肪性肝病（NAFLD）大鼠胰岛素以及胰岛素信号转导相关蛋白表达的影响。
Objective To investigate the effect of rosiglitazone and reduced glutathione on insulin signaling proteins in rats with nonalcoholic fatty liver disease(NAFLD). Methods NAFLD rats were produced.
此文就弹性蛋白酶在高脂血症、脂肪性肝病和肝纤维化治疗中的应用进展作一综述。
This article reviews the advance in the application of elastase to management of hyperlipoidemia, fatty liver disease and hepatic fibrosis.
脂肪性肝病(简称脂肪肝)是一种多病因引起的以肝细胞内中性脂肪异常沉积为主的临床病理综合征。
Fatty liver disease (FLD) is a clinical pathological syndrome characterized by unusual fat storing in liver cells with many causes.
应用推荐